United Kingdom - English - myHealthbox

roche products limited - naproxen - tablets - 500 mg - anti-inflammatory and antirheumatic products, non-steroids - treatment of rheumatoid arthritis, osteoarthrosis (degenerative arthritis), ankylosing spondylitis, acute gout, acute musculoskeletal disorders and dysmenorrhoea.

United Kingdom - English - myHealthbox

roche products limited - naproxen - tablets - 250mg - anti-inflammatory and antirheumatic products, non-steroids - treatment of rheumatoid arthritis, osteoarthrosis (degenerative arthritis), ankylosing spondylitis, acute gout, acute musculoskeletal disorders and dysmenorrhoea.

United Kingdom - English - myHealthbox

roche products limited - naproxen - gastro-resistant tablets - 250mg - anti-inflammatory and antirheumatic products, non-steroids - it is indicated in adults for the treatment of rheumatoid arthritis, osteoarthrosis (degenerative arthritis), ankylosing spondylitis, acute musculoskeletal disorders (such as sprains and strains, direct trauma, lumbosacral pain, cervical spondylitis, tenosynovitis and fibrositis) and dysmenorrhoea.

United Kingdom - English - myHealthbox

roche products limited - naproxen - gastro-resistant tablets - 375mg - anti-inflammatory and antirheumatic products, non-steroids - it is indicated in adults for the treatment of rheumatoid arthritis, osteoarthrosis (degenerative arthritis), ankylosing spondylitis, acute musculoskeletal disorders (such as sprains and strains, direct trauma, lumbosacral pain, cervical spondylitis, tenosynovitis and fibrositis) and dysmenorrhoea.

United Kingdom - English - myHealthbox

roche products limited - naproxen - gastro-resistant tablets - 500mg - anti-inflammatory and antirheumatic products, non-steroids - it is indicated in adults for the treatment of rheumatoid arthritis, osteoarthrosis (degenerative arthritis), ankylosing spondylitis, acute musculoskeletal disorders (such as sprains and strains, direct trauma, lumbosacral pain, cervical spondylitis, tenosynovitis and fibrositis) and dysmenorrhoea.

Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - naproxen, quantity: 750 mg - tablet, modified release - excipient ingredients: sunset yellow fcf; hypromellose; purified water; magnesium stearate - rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and the relief of chronic pain states in which there is an inflammatory component.

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer limited - tioconazole - nail solution - 283 mg/ml - imidazole and triazole derivatives

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - tioconazole - cutaneous solution - 283 milligram(s)/millilitre - imidazole and triazole derivatives; tioconazole

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - tioconazole - medicated nail lacquer - 283mg/1ml

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - tioconazole - cutaneous solution - 283 milligram(s)/millilitre - imidazole and triazole derivatives; tioconazole